Traditional Chinese medicine is a treasure of the Chinese nation, containing thousands of years of health concepts and practical experience. Inheriting traditional Chinese medicine well is to protect the treasures of ancient Chinese science and culture, and is also a key to opening the treasure trove of Chinese civilization. Since the 18th National Congress of the Communist Party of China, the Party Central Committee has placed traditional Chinese medicine in a more prominent position and made a series of major decisions and deployments, pointing out the direction for the inheritance, innovation, and development of traditional Chinese medicine. In order to further improve the innovation and inheritance of traditional Chinese medicine, tap into the charm of traditional Chinese medicine, and promote the complementary and coordinated development of traditional Chinese and Western medicine. Xinhua recently visited the Ruicheng Industrial Park of Yabao Pharmaceutical Group to explore the practice and exploration in the development of traditional Chinese medicine ethnic enterprises represented by Yabao. Yabao Pharmaceutical Group overlooks and strives to inherit and develop traditional Chinese medicine culture. Shanxi is a major province of traditional Chinese medicine culture and resources, with a profound accumulation of famous doctors, medicines, and formulas. In recent years, with the strong support of relevant departments, the traditional Chinese medicine industry in Shanxi has maintained a positive and innovative development, integrating industry, academia, and research. While better inheriting traditional Chinese medicine culture, it has achieved development and growth. A panoramic view of the Ruicheng Industrial Park of Yabao Pharmaceutical Group in July, during the midsummer, with strong sunlight and a blue sky that appears cleaner with a few white clouds. On the morning of the 7th, Xinhuanet came to Ruicheng County, Yuncheng, Shanxi Province, where Yabao Pharmaceutical Group Ruicheng Industrial Park is located in the south of Ruicheng County. When entering the park, the first thing we saw was the main office building of Yabao Pharmaceutical Group facing west and east. Entering the office building of Yabao Pharmaceutical Group, Chairman Ren Wuxian introduced that as the first pharmaceutical industry listed company in Shanxi and one of the first high-tech enterprises in Shanxi, Yabao Pharmaceutical has experienced more than 40 years of development. Nowadays, Yabao Pharmaceutical, which has been listed for 21 years, is actively exploring the path of cultivating and developing innovative industries through investment funds based on its core business and market positioning, focusing on cutting-edge emerging fields such as innovative drugs, cell therapy, and gene therapy, and cultivating the group's strategic emerging businesses. Chairman of Yabao Pharmaceutical Group, Ren Wuxian, walked through the hall towards the left and arrived at the Yabao Pharmaceutical Enterprise Exhibition Hall. Upon entering the exhibition hall, he saw the core values of "being a person with integrity and making medicine with heart". As a member of the Chinese ethnic pharmaceutical family, Yabao must focus its attention on consumers' health demands and produce reassuring and conscientious drugs, "explained Ren Wuxian. The exhibition hall also showcases the company structure, production base sandbox, and some drugs. The on-site staff introduced that in addition to some of the products displayed in the exhibition hall, Yabao also has over 300 varieties of traditional Chinese and Western medicine preparations, raw materials, and pharmaceutical packaging materials, mainly for children, women, elderly chronic disease drugs, and major health products. Some of the exhibits in the exhibition hall have formed a brand effect in the areas of children's medication, gynecological medication, and cardiovascular and cerebrovascular medication. There are three major families in the market: children's medication led by the "Dinggui" brand, gynecological medication led by the "Baiyu" brand, and cardiovascular and cerebrovascular medication led by the "Yabao" brand. Borrowing technology to improve the production efficiency of traditional Chinese medicine is the quintessence of the Chinese nation, not only rooted in more than 5000 years of traditional Chinese culture. Also carrying the suspension